601 related articles for article (PubMed ID: 27342214)
1. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
[TBL] [Abstract][Full Text] [Related]
2. Polycomb Repressive Complex 2 Enacts Wnt Signaling in Intestinal Homeostasis and Contributes to the Instigation of Stemness in Diseases Entailing Epithelial Hyperplasia or Neoplasia.
Oittinen M; Popp A; Kurppa K; Lindfors K; Mäki M; Kaikkonen MU; Viiri K
Stem Cells; 2017 Feb; 35(2):445-457. PubMed ID: 27570105
[TBL] [Abstract][Full Text] [Related]
3. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.
Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G
Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884
[TBL] [Abstract][Full Text] [Related]
4. Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.
Guo C; Balsara ZR; Hill WG; Li X
Development; 2017 Feb; 144(3):400-408. PubMed ID: 28049658
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.
Dauber KL; Perdigoto CN; Valdes VJ; Santoriello FJ; Cohen I; Ezhkova E
J Invest Dermatol; 2016 Aug; 136(8):1647-1655. PubMed ID: 26994968
[TBL] [Abstract][Full Text] [Related]
6. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
[TBL] [Abstract][Full Text] [Related]
7. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner.
Xie H; Xu J; Hsu JH; Nguyen M; Fujiwara Y; Peng C; Orkin SH
Cell Stem Cell; 2014 Jan; 14(1):68-80. PubMed ID: 24239285
[TBL] [Abstract][Full Text] [Related]
8. PRC2 Is Dispensable
Ferguson J; Devarajan M; DiNuoscio G; Saiakhova A; Liu CF; Lefebvre V; Scacheri PC; Atit RP
G3 (Bethesda); 2018 Feb; 8(2):491-503. PubMed ID: 29223978
[TBL] [Abstract][Full Text] [Related]
9. Polycomb repression complex 2 is required for the maintenance of retinal progenitor cells and balanced retinal differentiation.
Fujimura N; Kuzelova A; Ebert A; Strnad H; Lachova J; Machon O; Busslinger M; Kozmik Z
Dev Biol; 2018 Jan; 433(1):47-60. PubMed ID: 29137925
[TBL] [Abstract][Full Text] [Related]
10. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2.
Kong X; Chen L; Jiao L; Jiang X; Lian F; Lu J; Zhu K; Du D; Liu J; Ding H; Zhang N; Shen J; Zheng M; Chen K; Liu X; Jiang H; Luo C
J Med Chem; 2014 Nov; 57(22):9512-21. PubMed ID: 25369470
[TBL] [Abstract][Full Text] [Related]
11. Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation.
Zhang J; Taylor RJ; La Torre A; Wilken MS; Cox KE; Reh TA; Vetter ML
Dev Biol; 2015 Jul; 403(2):128-38. PubMed ID: 25989023
[TBL] [Abstract][Full Text] [Related]
12. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
[TBL] [Abstract][Full Text] [Related]
13. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
14. Polycomb repressive complex 2 is required for MLL-AF9 leukemia.
Neff T; Sinha AU; Kluk MJ; Zhu N; Khattab MH; Stein L; Xie H; Orkin SH; Armstrong SA
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5028-33. PubMed ID: 22396593
[TBL] [Abstract][Full Text] [Related]
15. Polycomb Complex PRC1 Preserves Intestinal Stem Cell Identity by Sustaining Wnt/β-Catenin Transcriptional Activity.
Chiacchiera F; Rossi A; Jammula S; Piunti A; Scelfo A; Ordóñez-Morán P; Huelsken J; Koseki H; Pasini D
Cell Stem Cell; 2016 Jan; 18(1):91-103. PubMed ID: 26526724
[TBL] [Abstract][Full Text] [Related]
16. The Transcription Co-Repressors MTG8 and MTG16 Regulate Exit of Intestinal Stem Cells From Their Niche and Differentiation Into Enterocyte vs Secretory Lineages.
Baulies A; Angelis N; Foglizzo V; Danielsen ET; Patel H; Novellasdemunt L; Kucharska A; Carvalho J; Nye E; De Coppi P; Li VSW
Gastroenterology; 2020 Oct; 159(4):1328-1341.e3. PubMed ID: 32553763
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer.
Kim W; Bird GH; Neff T; Guo G; Kerenyi MA; Walensky LD; Orkin SH
Nat Chem Biol; 2013 Oct; 9(10):643-50. PubMed ID: 23974116
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M; Fujita S; Katsumoto T; Yamagata K; Ogawara Y; Hattori A; Kagiyama Y; Honma D; Araki K; Inoue T; Kato A; Inaki K; Wada C; Ono Y; Yamamoto M; Miura O; Nakashima Y; Kitabayashi I
Cancer Sci; 2019 Jan; 110(1):194-208. PubMed ID: 30343511
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-323-3p regulates the activity of polycomb repressive complex 2 (PRC2) via targeting the mRNA of embryonic ectoderm development (Eed) gene in mouse embryonic stem cells.
Zhang Y; Teng F; Luo GZ; Wang M; Tong M; Zhao X; Wang L; Wang XJ; Zhou Q
J Biol Chem; 2013 Aug; 288(33):23659-65. PubMed ID: 23821546
[TBL] [Abstract][Full Text] [Related]
20. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
